In-cell intrabody selection from a diverse human library identifies C12orf4 protein as a new player in rodent mast cell degranulation

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Mazuc, Elsa ^a,b,c   Guglielmi, Laurence ^a,b,c   Bec, Nicole ^a,b,c   Parez, Vincent ^a,b,c   Hahn, Chang S ^d   Mollevi, Caroline ^c   Parrinello, Hugues ^e   Desvignes, Jean Pierre ^e   Larroque, Christian ^a,b,c   Jupp, Ray ^d   Dariavach, Piona ^a,b,c   Martineau, Pierre ^a,b,c  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

^c CENTRE VAL D AURELLE   (France)

^d SANOFI   (France)

^e INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; C12ORF4 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANIMAL; C57BL MOUSE; CYTOLOGY; DEGRANULATION; FEMALE; HUMAN; IMMUNOLOGY; MAST CELL; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ANTIBODIES; CELL DEGRANULATION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MICE; MICE, INBRED C57BL;

EID: 84905985710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104998     Document Type: Article

References (53)

1. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CMM, et al. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786. doi:10.1146/annurev. immunol.21.120601.141025. (Pubitemid 40563184)
2. Bounab Y, Getahun A, Cambier JC, Daëron M (2013) Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells. Curr Opin Immunol 25: 313-320. doi:10.1016/j.coi.2013.04.001.
3. Riccaboni M, Bianchi I, Petrillo P (2010) Spleen tyrosine kinases: biology, therapeutic targets and drugs. Drug Discov Today 15: 517-530. doi:10.1016/j.drudis.2010.05.001.
4. D'Cruz OJ, Uckun FM (2012) Targeting Spleen Tyrosine Kinase (Syk) for Treatment of Human Disease. J Pharm Drug Deliv Res 01: doi:10.4172/2325-9604. 1000107. doi:10.4172/2325-9604.1000107.
5. Meltzer EO, Berkowitz RB, Grossbard EB (2005) An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment. J Allergy Clin Immunol 115: 791-796. doi:10.1016/j.jaci.2005.01. 040. (Pubitemid 40460855)
6. Norman P (2009) A novel Syk kinase inhibitor suitable for inhalation: R-343(?)-WO-2009031011. Expert Opin Ther Pat 19: 1469-1472. doi:10.1517/ 13543770903059281.
7. Mazuc E, Villoutreix BO, Malbec O, Roumier T, Fleury S, et al. (2008) A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally. J Allergy Clin Immunol 122: 188-194, 194.e1-3. doi:10.1016/j.jaci.2008.04.026.
8. Villoutreix BO, Laconde G, Lagorce D, Martineau P, Miteva MA, et al. (2011) Tyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screening. PloS One 6: e21117. doi:10.1371/journal.pone.0021117.
9. Dauvillier S, Merida P, Visintin M, Cattaneo A, Bonnerot C, et al. (2002) Intracellular single-chain variable fragments directed to the Src homology 2 domains of Syk partially inhibit Fc epsilon RI signaling in the RBL-2H3 cell line. J Immunol 169: 2274-2283. (Pubitemid 34920967)
10. Gargano N, Cattaneo A (1997) Rescue of a neutralizing anti-viral antibody fragment from an intracellular polyclonal repertoire expressed in mammalian cells. FEBS Lett 414: 537-540. (Pubitemid 27390662)
11. Gargano N, Cattaneo A (1997) Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment. J Gen Virol 78 (Pt 10): 2591-2599. (Pubitemid 27470002)
12. Cattaneo A, Biocca S (1999) The selection of intracellular antibodies. Trends Biotechnol 17: 115-121. (Pubitemid 29348463)
13. Philibert P, Stoessel A, Wang W, Sibler A-P, Bec N, et al. (2007) A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm. BMC Biotechnol 7: 81. doi:10.1186/1472-6750-7-81.
14. Guglielmi L, Denis V, Vezzio-Vié N, Bec N, Dariavach P, et al. (2011) Selection for intrabody solubility in mammalian cells using GFP fusions. Protein Eng Des Sel PEDS 24: 873-881. doi:10.1093/protein/gzr049.
15. Li J, Tibshirani R (2011) Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data. Stat Methods Med Res. Available: http://www.ncbi.nlm.nih.gov/pubmed/22127579. Accessed 28 February 2012.
16. Giudicelli V, Duroux P, Ginestoux C, Folch G, Jabado-Michaloud J, et al. (2006) IMGT/LIGM-DB, the IMGT(R) comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucl Acids Res 34: D781-784.
17. Dauvillier S, Merida P, Visintin M, Cattaneo A, Bonnerot C, et al. (2002) Intracellular single-chain variable fragments directed to the Src homology 2 domains of Syk partially inhibit Fc epsilon RI signaling in the RBL-2H3 cell line. J Immunol 169: 2274-2283. (Pubitemid 34920967)
18. Schneider P (2000) Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins. Methods Enzymol 322: 325-345.
19. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860. doi:10.1038/nprot.2006.468.
20. Fisher AC, DeLisa MP (2009) Efficient Isolation of Soluble Intracellular Single-chain Antibodies using the Twin-arginine Translocation Machinery. J Mol Biol 385: 299-311. doi:10.1016/j.jmb.2008.10.051.
21. Demo SD, Masuda E, Rossi AB, Throndset BT, Gerard AL, et al. (1999) Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. Cytometry 36: 340-348. (Pubitemid 29344470)
22. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, et al. (2001) Regulation of mast cell survival by IgE. Immunity 14: 791-800. (Pubitemid 32592425)
23. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, et al. (2001) Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14: 801-811. (Pubitemid 32592426)
24. Ward ES, Güssow D, Griffiths AD, Jones PT, Winter G (1989) Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 341: 544-546. doi:10.1038/341544a0. (Pubitemid 19252529)
25. Su C, Nguyen VK, Nei M (2002) Adaptive Evolution of Variable Region Genes Encoding an Unusual Type of Immunoglobulin in Camelids. Mol Biol Evol 19: 205-215. (Pubitemid 34184592)
26. Tanaka T, Lobato MN, Rabbitts TH (2003) Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies. J Mol Biol 331: 1109-1120. (Pubitemid 36969968)
27. Kalesnikoff J, Galli SJ (2008) New developments in mast cell biology. Nat Immunol 9: 1215-1223. doi:10.1038/ni.f.216.
28. Genini S, Nguyen TT, Malek M, Talbot R, Gebert S, et al. (2006) Radiation hybrid mapping of 18 positional and physiological candidate genes for arthrogryposis multiplex congenita on porcine chromosome 5. Anim Genet 37: 239-244. doi:10.1111/j.1365-2052.2006.01447.x. (Pubitemid 43806491)
29. Yea K, Zhang H, Xie J, Jones TM, Yang G, et al. (2013) Converting stem cells to dendritic cells by agonist antibodies from unbiased morphogenic selections. Proc Natl Acad Sci U S A 110: 14966-14971. doi:10.1073/pnas. 1313671110.
30. Xie J, Yea K, Zhang H, Moldt B, He L, et al. (2014) Prevention of Cell Death by Antibodies Selected from Intracellular Combinatorial Libraries. Chem Biol 21: 274-283. doi:10.1016/j.chembiol.2013.12.006.
31. Ravn U, Gueneau F, Baerlocher L, Osteras M, Desmurs M, et al. (2010) Bypassing in vitro screening-next generation sequencing technologies applied to antibody display and in silico candidate selection. Nucleic Acids Res 38: e193. doi:10.1093/nar/gkq789.
32. Paz K, Brennan LA, Iacolina M, Doody J, Hadari YR, et al. (2005) Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation. Mol Cancer Ther 4: 1801-1809. doi:10.1158/1535-7163.MCT-05-0174. (Pubitemid 41685315)
33. Griffin H, Elston R, Jackson D, Ansell K, Coleman M, et al. (2006) Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting. J Mol Biol 355: 360-378. (Pubitemid 41785744)
34. Cohen PA, Mani JC, Lane DP (1998) Characterization of a new intrabody directed against the N-terminal region of human p53. Oncogene 17: 2445-2456. (Pubitemid 28544714)
35. Martineau P, Jones P, Winter G (1998) Expression of an antibody fragment at high levels in the bacterial cytoplasm. J Mol Biol 280: 117-127. (Pubitemid 28312810)
36. Tanaka T, Williams RL, Rabbitts TH (2007) Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS. EMBO J 26: 3250-3259. doi:10.1038/sj.emboj.7601744. (Pubitemid 47057484)
37. Miller TW, Zhou C, Gines S, MacDonald ME, Mazarakis ND, et al. (2005) A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's disease. Neurobiol Dis 19: 47-56. doi:10.1016/j.nbd.2004.11.003. (Pubitemid 40552820)
38. Cassimeris L, Guglielmi L, Denis V, Larroque C, Martineau P (2013) Specific In Vivo Labeling of Tyrosinated a-Tubulin and Measurement of Microtubule Dynamics Using a GFP Tagged, Cytoplasmically Expressed Recombinant Antibody. PLoS ONE 8: e59812. doi:10.1371/journal.pone.0059812.
39. Caussinus E, Kanca O, Affolter M (2012) Fluorescent fusion protein knockout mediated by anti-GFP nanobody. Nat Struct Mol Biol 19: 117-121. doi:10.1038/nsmb.2180.
40. Butler DC, Messer A (2011) Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments. PLoS ONE 6: e29199. doi:10.1371/journal. pone.0029199.
41. Sibler A-P, Nordhammer A, Masson M, Martineau P, Trave G, et al. (2003) Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals. Exp Cell Res 286: 276-287. (Pubitemid 36566440)
42. Böldicke T (2007) Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER. J Cell Mol Med 11: 54-70. doi:10.1111/j.1582-4934.2007.00002.x.
43. Rabu C, McIntosh R, Jurasova Z, Durrant L (2012) Glycans as targets for therapeutic antitumor antibodies. Future Oncol Lond Engl 8: 943-960. doi:10.2217/fon.12.88.
44. Quintana FJ, Yeste A, Weiner HL, Covacu R (2012) Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis. J Neuroimmunol 248: 53-57. doi:10.1016/j.jneuroim.2012.01.002.
45. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, et al. (2009) A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137: 835-848. doi:10.1016/j.cell.2009.05.006.
46. Beronja S, Janki P, Heller E, Lien W-H, Keyes BE, et al. (2013) RNAi screens in mice identify physiological regulators of oncogenic growth. Nature 501: 185-190. doi:10.1038/nature12464.
47. Huang S, Hölzel M, Knijnenburg T, Schlicker A, Roepman P, et al. (2012) MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling. Cell 151: 937-950. doi:10.1016/j.cell.2012.10. 035.
48. Kontermann RE (2004) Intrabodies as therapeutic agents. Methods 34: 163-170.
49. Alvarez RD, Barnes MN, Gomez-Navarro J, Wang M, Strong TV, et al. (2000) A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin Cancer Res 6: 3081-3087. (Pubitemid 30637731)
50. Swaminathan J, Ehrhardt C (2012) Liposomal delivery of proteins and peptides. Expert Opin Drug Deliv 9: 1489-1503. doi:10.1517/17425247.2012.735658.
51. Freund G, Sibler A-P, Desplancq D, Oulad-Abdelghani M, Vigneron M, et al. (2013) Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cells. mAbs 5: 518-522. doi:10.4161/mabs.25084.
52. Marschall ALJ, Frenzel A, Schirrmann T, Schüngel M, Dubel S (2011) Targeting antibodies to the cytoplasm. mAbs 3: 3-16. doi:10.4161/mabs.3.1.14110.
53. D'Agostino R, Belanger A, D'Agostino Jr. R (n.d.) A suggestion for using powerful and informative tests of normality. Am Stat 44: 316-321.